PL2302068T3 - Sposób wytwarzania rekombinowanych polipeptydów - Google Patents

Sposób wytwarzania rekombinowanych polipeptydów

Info

Publication number
PL2302068T3
PL2302068T3 PL10009128.9T PL10009128T PL2302068T3 PL 2302068 T3 PL2302068 T3 PL 2302068T3 PL 10009128 T PL10009128 T PL 10009128T PL 2302068 T3 PL2302068 T3 PL 2302068T3
Authority
PL
Poland
Prior art keywords
preparation
recombinant polypeptides
relates
periplasm
polypeptide
Prior art date
Application number
PL10009128.9T
Other languages
English (en)
Inventor
Günter Stempfer
Norbert Palma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=28460018&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2302068(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL2302068T3 publication Critical patent/PL2302068T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
PL10009128.9T 2003-08-20 2004-08-19 Sposób wytwarzania rekombinowanych polipeptydów PL2302068T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0319601.1A GB0319601D0 (en) 2003-08-20 2003-08-20 Production process

Publications (1)

Publication Number Publication Date
PL2302068T3 true PL2302068T3 (pl) 2016-09-30

Family

ID=28460018

Family Applications (2)

Application Number Title Priority Date Filing Date
PL04764305T PL1658376T3 (pl) 2003-08-20 2004-08-19 Sposób wytwarzania rekombinowanych polipeptydów
PL10009128.9T PL2302068T3 (pl) 2003-08-20 2004-08-19 Sposób wytwarzania rekombinowanych polipeptydów

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL04764305T PL1658376T3 (pl) 2003-08-20 2004-08-19 Sposób wytwarzania rekombinowanych polipeptydów

Country Status (9)

Country Link
US (1) US8426168B2 (pl)
EP (2) EP1658376B1 (pl)
JP (1) JP4750030B2 (pl)
AT (1) ATE503003T1 (pl)
DE (1) DE602004031955D1 (pl)
GB (1) GB0319601D0 (pl)
PL (2) PL1658376T3 (pl)
SI (2) SI2302068T1 (pl)
WO (1) WO2005019466A2 (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0425534D0 (en) * 2004-11-19 2004-12-22 Celltech R&D Ltd Process for obtaining antibodies
WO2006121165A1 (ja) * 2005-05-12 2006-11-16 Ajinomoto Co., Inc. タンパク質の製造法
GB201001791D0 (en) 2010-02-03 2010-03-24 Ucb Pharma Sa Process for obtaining antibodies
GB201106225D0 (en) * 2011-04-13 2011-05-25 Glaxosmithkline Biolog Sa Fermentation process
SG11201404991YA (en) 2012-02-23 2014-09-26 Stage Cell Therapeutics Gmbh Chromatographic isolation of cells and other complex biological materials
CA2896157A1 (en) 2012-12-27 2014-07-03 Glycovaxyn Ag Methods and compositions relating to crm197
JP6807327B2 (ja) 2014-12-22 2021-01-06 ユーシービー バイオファルマ エスアールエル タンパク質製造
MA45489A (fr) 2015-10-22 2018-08-29 Juno Therapeutics Gmbh Procédés de culture de cellules, kits et appareil associés
RU2761555C2 (ru) 2015-10-22 2021-12-09 Джуно Терапьютикс Гмбх Способы, наборы, средства и устройства для трансдукции
AU2018260380B2 (en) 2017-04-27 2025-02-13 Juno Therapeutics Gmbh Oligomeric particle reagents and methods of use thereof
WO2020089343A1 (en) 2018-10-31 2020-05-07 Juno Therapeutics Gmbh Methods for selection and stimulation of cells and apparatus for same
US20220403426A1 (en) * 2019-11-05 2022-12-22 Basf Se Method of storing a biocatalyst
CN111996225A (zh) * 2020-09-18 2020-11-27 深圳科兴药业有限公司 一种利用微生物生产高活性重组人干扰素α2b的发酵方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4315852A (en) 1980-11-26 1982-02-16 Schering Corporation Extraction of interferon from bacteria
EP0177343B1 (en) * 1984-10-05 1992-07-22 Genentech, Inc. Dna, cell cultures and methods for the secretion of heterologous proteins and periplasmic protein recovery
US4680262A (en) † 1984-10-05 1987-07-14 Genentech, Inc. Periplasmic protein recovery
DE3511011A1 (de) 1985-03-27 1986-10-02 Hoechst Ag, 6230 Frankfurt Verfahren zur isolierung und reinigung von (alpha)-interferonen
EP0604580A1 (en) 1991-09-19 1994-07-06 Genentech, Inc. EXPRESSION IN E. COLI OF ANTIBODY FRAGMENTS HAVING AT LEAST A CYSTEINE PRESENT AS A FREE THIOL, USE FOR THE PRODUCTION OF BIFUNCTIONAL F(ab') 2? ANTIBODIES
EP0587427B1 (en) * 1992-09-09 1998-06-03 MITSUI TOATSU CHEMICALS, Inc. Process for the production of human growth hormone
EP0626448A3 (de) * 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
US6337205B1 (en) * 1998-01-06 2002-01-08 Integrated Biosystems, Inc Cryopreservation vial apparatus and methods
GB9808720D0 (en) * 1998-04-23 1998-06-24 Smithkline Beecham Biolog Novel compounds
US6160089A (en) * 1998-07-08 2000-12-12 Mitsui Chemicals, Inc. Method for secretory production of human growth hormone
ES2308981T3 (es) * 1999-04-09 2008-12-16 Universitat Zurich Metodo para la estabilizacion de las inmunoglobulinas hibridas o fragmentos de inmunoglobulina y fragmentos anti-egp-2-scfv estabilizado.
KR100360594B1 (ko) * 2000-01-19 2002-11-13 한미약품공업 주식회사 인간 인터페론 알파의 발현 분비벡터 및 이를 이용한인터페론 알파의 생산 방법
GB0013810D0 (en) 2000-06-06 2000-07-26 Celltech Chiroscience Ltd Biological products
WO2003004599A2 (en) * 2001-07-02 2003-01-16 Insight Biopharmaceuticals Ltd. Methods of making and using expression constructs for the expression of recombinant proteins
WO2006060282A2 (en) † 2004-11-30 2006-06-08 Merial Limited Mixing devices for chemical lysis of cells
CA2803091C (en) † 2009-07-27 2018-05-22 The University Of Wyoming Research Corporation D/B/A/ Western Research Institute Biological clean fuel processing systems and methods
EP4062928A3 (en) † 2010-02-04 2022-11-30 BioMarin Pharmaceutical Inc. Prokaryotic phenylalanine ammonia-lyases and their use for treating phenylketonuria and hyperphenylalaninemia

Also Published As

Publication number Publication date
US8426168B2 (en) 2013-04-23
GB0319601D0 (en) 2003-09-24
EP1658376B1 (en) 2011-03-23
EP2302068B1 (en) 2016-03-30
DE602004031955D1 (de) 2011-05-05
EP1658376A2 (en) 2006-05-24
SI1658376T1 (sl) 2011-06-30
SI2302068T1 (sl) 2016-07-29
WO2005019466A3 (en) 2005-05-06
EP2302068A1 (en) 2011-03-30
PL1658376T3 (pl) 2011-08-31
JP4750030B2 (ja) 2011-08-17
JP2007502609A (ja) 2007-02-15
WO2005019466A2 (en) 2005-03-03
US20060269990A1 (en) 2006-11-30
ATE503003T1 (de) 2011-04-15
EP2302068B2 (en) 2022-10-26

Similar Documents

Publication Publication Date Title
SI1658376T1 (sl) Postopek za pripravo rekombinantnih polipeptidov
IL187293A (en) Methods for producing glycosylation proteins at site n and host prokaryotic organisms
MX348154B (es) Anticuerpos de enlace a il-1-beta y fragmentos de los mismos.
MY169472A (en) Refolding of recombinant proteins
WO2004033659A3 (en) Novel tumor suppressor gene and compositions and methods for making and using the same
AU2002360331A8 (en) Egviii endoglucanase and nucleic acids encoding the same
MY170126A (en) Fc containing polypeptides with altered glycosylation and reduced effector function
UA98620C2 (uk) Атенуйований вірус класичної лихоманки свиней, що містить модифікований глікопротеїн е2
WO2004048517A3 (en) Method for reducing or preventing modification of a polypeptide in solution
IL183608A0 (en) Rhamnose promoter expression system
MY149128A (en) A method for the mass production of immunoglobulin fc region deleted initial methionine residues
MX2009012326A (es) Peptidos de señalizacion.
WO2002076486A3 (en) Histidine-rich glycoprotein
JO2991B1 (ar) بروتينات رابطة لمولد ضد المستقبل ايه للانترليوكين 17
ZA202304029B (en) Cxcl9 and variants thereof for immunotherapy of cancer diseases
WO2001047956A3 (en) Method for obtaining proteins having improved functional characteristics
WO2005017174A3 (en) Process for the purification of recombinant polypeptides
ATE497007T1 (de) Polynukleotide, die für prenylproteasen aus pflanzen kodieren
WO2004039834A3 (en) Recombinant protein variants
WO2003022868A3 (en) Metal binding proteins and associated methods
IL166387A0 (en) Method for enhancing yield of recombinant protein production from plants
WO2002083713A3 (en) Echinocandin process
AU2003263161A8 (en) Method for making recombinant proteins
WO2005066208A3 (en) Method for production of recombinant growth hormone in form of hybrid protein
WO2009083968A8 (en) Novel protein